Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Envision renews contract with UnitedHealthcare after billing practices battle

After months of back-and-forth, Envision Healthcare has renewed its contract with UnitedHealthcare.

Thumbnail

Growth in U.S. healthcare spending slowed in 2017

National health spending grew by 3.9 percent in 2017, about 1 percent slower growth than the previous year, according to the Office of the Actuary at CMS. Total healthcare spending reached $3.5 trillion in 2017, or $10,739 per person.

Thumbnail

Consumers worry about hospital mergers

It’s no secret the healthcare industry is undergoing massive consolidation, and hospital mergers and acquisitions are a concern among more than 60 percent of American adults, according to a new survey.

Thumbnail

Hospital groups launch suit against HHS

Hospital groups have launched a lawsuit against HHS over its new outpatient prospective payment system rule, which was finalized in November.

Thumbnail

Humana to buy back $750M in stocks

Health insurance and services provider Humana has announced it will accelerate stock repurchase of $750 million.

Thumbnail

CVS launches new PBM pricing model

As CVS Health continues to deal with the closure of its $69 billion acquisition of Aetna, its pharmacy benefit manager (PBM) branch is moving ahead with a new pricing model. The new focus could help guarantee net cost predictability and simplify pricing.

Thumbnail

CVS-Aetna deal faces hurdle as WellCare buys out Part D biz

CVS Health has closed its $69 billion acquisition of health insurer Aetna after the deal was approved by all necessary regulators, but the transaction has hit a snag after a judge requested more information from the Department of Justice.

Thumbnail

Trump administration details state of healthcare competition

In the midst of a major consolidation period in the healthcare industry, a new report from the Trump administration sheds light on the current state of competition in the space.

Around the web

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Trimed Popup
Trimed Popup